Altana’s Omnaris Is Both Approved And “Approvable” For Allergenic Rhinitis
This article was originally published in The Pink Sheet Daily
Executive Summary
Ciclesonide nasal spray is approved in ages 12 and older, and “approvable” in ages two to 11, Altana says.
You may also be interested in...
Sepracor Plans Alvesco, Omnaris Drug Launches Following Acquisition From Nycomed
Sepracor’s 1,600-person sales force will promote the asthma and allergic rhinitis treatments.
Sepracor Plans Alvesco, Omnaris Drug Launches Following Acquisition From Nycomed
Sepracor’s 1,600-person sales force will promote the asthma and allergic rhinitis treatments.
Nycomed Seeks U.S. Partner To Promote Alvesco Asthma Inhaler And Intranasal Omnaris
FDA approved Alvesco to treat asthma in patients 12 and older Jan. 10, the Swiss pharma tells “The Pink Sheet” DAILY.